查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462761

影像導航放射治療(IGRT)市場至2030年的預測：按產品、技術、應用、最終用戶和地區的全球分析

Image Guided Radiotherapy Market Forecasts to 2030 - Global Analysis By Product (Software, Hardware, Accessories and Service), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球影像導航放射治療（IGRT）市場規模將達20.5億美元，預測期內年複合成長率為7.2%，預計到2030年將達到33.4億美元。

影像導航放射治療（IGRT）是一種精準放射治療，利用影像技術引導放射線到達腫瘤。 IGRT 使臨床醫生能夠即時觀察腫瘤和周圍組織，更準確地瞄準輻射並最大限度地減少對健康組織的損害。這種方法可以提高治療效果，同時減少副作用。 IGRT 對於治療期間移動或位於重要器官附近的腫瘤特別有效，改善治療結果並提高患者安全。

根據美國癌症協會預測，到2040年，全球癌症病例數預計將達到2840萬，比2020年增加47%，其中由於人口結構變化，預計增幅最大的是發展中國家，超過60%。癌症患者接受某種形式的放射線治療作為治療的一部分。

癌症盛行率上升

隨著癌症發病率的增加，對高精度和微創的先進治療方法的需求不斷成長。 IGRT 利用最先進的影像技術，越來越成為癌症治療的首選選擇，因為它可以精確靶向腫瘤，同時保護健康組織。對更有效和量身定做的癌症治療的需求不斷成長，使 IGRT 成為一種關鍵的解決方案，隨著癌症治療的擴展，推動其採用和市場成長。

缺乏熟練的專業人員

缺乏訓練有素的專業人員是影像導航放射治療（IGRT）市場擴張的主要障礙。 IGRT 技術的成功使用需要熟悉其操作和解釋的熟練醫療人員。如果沒有足夠的勞動力，醫療機構可能難以提供 IGRT 服務，導致 IGRT 技術利用不足並抑制市場成長潛力。

放射治療設備持續創新

放射治療設備的持續創新提高了治療的準確性、效率和患者的治療效果。改進的顯像模式、即時監測和自動治療輸送系統等先進功能提高了腫瘤靶向的精確度，同時最大限度地減少對周圍健康組織的損害。這些創新吸引了尋求尖端解決方案並提高採用率的醫療保健提供者。此外，技術進步使得更緊湊、更具成本效益的 IGRT 系統的開發成為可能，擴大了患者群體的覆蓋範圍。

昂貴的設備和治療費用

IGRT 設備和治療的高昂成本限制了其可近性，特別是在醫療保健預算有限的地區。 IGRT 系統所需的大量初始投資和持續治療成本阻礙了醫療機構採用該技術。此外，患者面臨經濟負擔，醫療保健提供者在確保 IGRT 手術償付方面面臨挑戰。因此，高昂的設備和處理成本阻礙了IGRT的普及和使用，阻礙了市場拓展。

COVID-19 的影響

COVID-19 的爆發對影像導航放射治療（IGRT）市場產生了各種影響。最初，醫療設施的關閉和資源的重新調整擾亂了治療計劃，並減緩了新設備的推出，但由於強勁的需求和對癌症護理的日益關注，市場已出現反彈。此外，疫情加速了遠端醫療和遠端監控技術的採用，這可能對 IGRT 服務的提供和獲取方式產生長期影響，推動市場成長。

3D超音波領域預計在預測期內成為最大的產業

3D超音波領域預計將出現良好的成長。 3D超音波透過提供腫瘤部位的即時、高解析度成像來提高治療的精確度和準確度。該技術提供了腫瘤邊界和周圍解剖結構的更好可視化，使腫瘤學家能夠非常精確地客製化放射治療。將其納入 IGRT 工作流程可以改善患者的治療效果和治療效果。

預計腦腫瘤領域在預測期內的年複合成長率最高。

預計腦腫瘤領域在預測期內將出現最高的年複合成長率。 IGRT 利用 MRI、CT 和 PET 掃描等先進影像技術即時顯示治療的腫瘤並實現精確的放射治療。這種方法可以提高治療效果，同時降低副作用的風險。它還有助於根據患者的個別需求制定個人化治療計劃，最佳化腦腫瘤患者的治療結果。

佔有率最大的地區

由於癌症發病率增加和醫療基礎設施的進步，預計亞太地區在預測期內將佔據最大的市場佔有率。中國和印度等新興經濟體是主要貢獻者，這得益於不斷上漲的醫療費用和更多先進治療方法的機會。由於有利的法規環境和不斷提高的癌症治療意識，亞太地區的 IGRT 市場預計將持續成長。

年複合成長率最高的地區：

由於其高癌症發病率和強大的醫療基礎設施，預計歐洲在預測期內將經歷最高的年複合成長率。美國憑藉著廣泛的研發活動和對醫療保健技術的大量投資主導了市場。先進成像技術和軟體解決方案的更多採用以及有利的償付政策推動市場擴張。北美 IGRT 市場致力於精準醫療和以患者為中心的護理，有望實現持續成長和技術進步。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球影像導航放射治療（IGRT）市場：依產品

  • 軟體
    • 治療計畫軟體
    • 影像處理軟體
    • 影像登錄軟體
    • 治療提供軟體
    • 品質保證軟體
  • 硬體
    • 線性加速器（LINAC）
    • X光系統
    • 超音波系統
  • 配件
    • IGRT Tables
    • IGRT治療床
    • IGRT標記
    • IGRT校準儀
    • IGRT固定裝置
  • 服務
    • 安裝服務
    • 保養及維修服務

第6章 全球影像導航放射治療（IGRT）市場：依技術分類

  • 錐狀射束掃描（CBCT）
  • 3D超音波
  • MRI 導引放射治療（MRI-RT）
  • 正子斷層掃描（PET）導引放射治療（PET-RT）
  • 電腦斷層掃描（CT）導引放射治療（CT-RT）
  • 其他技術

第7章 全球影像導航放射治療（IGRT）市場：依應用分類

  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 頭頸癌
  • 腦腫瘤
  • 婦科癌症
  • 其他用途

第8章 全球影像導航放射治療（IGRT）市場：依最終使用者分類

  • 醫院
  • 放射治療中心
  • 癌症研究所
  • 其他最終用戶

第9章 全球影像導航放射治療（IGRT）市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Siemens Healthineers
  • Elekta AB
  • Accuray Incorporated
  • ViewRay, Inc.
  • Brainlab AG
  • RaySearch Laboratories
  • Mevion Medical Systems
  • C-RAD AB
  • IBA Dosimetry GmbH
  • Philips Healthcare
  • Hitachi Medical Systems
  • Theragenics Corporation
  • Nanobiotix
  • Xstrahl Limited
Product Code: SMRC25812

According to Stratistics MRC, the Global Image Guided Radiotherapy Market is accounted for $2.05 billion in 2023 and is expected to reach $3.34 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Image Guided Radiotherapy (IGRT) is a precise form of radiation therapy that utilizes imaging technology to guide the delivery of radiation to tumours. IGRT enables clinicians to visualize the tumor and surrounding tissues in real-time, allowing for more accurate targeting of radiation and minimizing damage to healthy tissue. This approach enhances treatment effectiveness while reducing side effects. IGRT is particularly valuable for tumours that move during treatment or are located near critical organs, offering improved outcomes and increased patient safety.

According to the American Cancer Society, the burden of cancer worldwide is expected to reach ~28.4 million cases by 2040, increased by 47% from 2020, with greater increases in developing countries due to demographic changes and over 60% of cancer patients undergo some form of radiation therapy as part of their treatment.

Market Dynamics:

Driver:

Rising prevalence of cancer

With cancer incidence rates on the rise, there's an amplified demand for advanced treatment modalities that offer precision and minimal invasiveness. IGRT, leveraging cutting-edge imaging technologies, enables precise tumor targeting while sparing healthy tissues, making it an increasingly preferred option in oncology. This growing demand for more effective and tailored cancer treatments positions IGRT as a pivotal solution, driving its adoption and market growth amidst the expanding landscape of cancer care.

Restraint:

Lack of skilled professionals

The scarcity of trained professionals poses a significant obstacle to the expansion of the Image Guided Radiotherapy (IGRT) market. Successful utilization of IGRT technology necessitates skilled healthcare practitioners proficient in its operation and interpretation. Without an adequate workforce, healthcare facilities may struggle to offer IGRT services, leading to underutilization of IGRT technology and hindering its market growth potential.

Opportunity:

Continuous innovations in radiotherapy equipment

Continuous innovations in radiotherapy equipment enhance treatment precision, efficiency, and patient outcomes. Advanced features such as improved imaging modalities, real-time monitoring, and automated treatment delivery systems increase the accuracy of tumor targeting while minimizing damage to surrounding healthy tissue. These innovations attract healthcare providers seeking state-of-the-art solutions, boosting adoption rates. Additionally, technological advancements enable the development of more compact and cost-effective IGRT systems, expanding accessibility to a broader patient population.

Threat:

High cost of equipment and treatment

The high cost of equipment and treatment in IGRT limits accessibility, particularly in regions with constrained healthcare budgets. The substantial initial investment required for IGRT systems and ongoing treatment expenses can deter healthcare facilities from adopting this technology. Additionally, patients face financial burdens, and healthcare providers encounters challenges in securing reimbursement for IGRT procedures. Consequently, the high cost of equipment and treatment hampers the widespread adoption and utilization of IGRT, impeding market expansion.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the image guided radiotherapy market. While it initially led to disruptions in treatment schedules and a slowdown in installations of new equipment due to healthcare facility closures and reprioritization of resources, there has been a subsequent rebound driven by pent-up demand and a growing emphasis on cancer care. Furthermore, the pandemic has accelerated the adoption of telemedicine and remote monitoring technologies, which could have long-term implications for how IGRT services are delivered and accessed, potentially fostering market growth.

The 3D ultrasound segment is expected to be the largest during the forecast period

The 3D ultrasound segment is estimated to have a lucrative growth. By providing real-time, high-resolution imaging of tumor sites, 3D ultrasound enhances the precision and accuracy of treatment delivery. This technology allows for better visualization of tumor boundaries and surrounding anatomy, enabling oncologists to tailor radiation therapy with utmost precision. Its incorporation into IGRT workflows enhances patient outcomes and treatment efficacy.

The brain tumours segment is expected to have the highest CAGR during the forecast period

The brain tumours segment is anticipated to witness the highest CAGR growth during the forecast period. Utilizing advanced imaging techniques such as MRI, CT, and PET scans, IGRT enables real-time visualization of tumours during treatment, allowing for accurate radiation delivery. This approach enhances treatment efficacy while reducing the risk of side effects. It also facilitates personalized treatment plans tailored to individual patient needs, optimizing outcomes for brain tumor patients.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing cancer incidence and advancements in healthcare infrastructure. Emerging economies such as China and India are key contributors, supported by rising healthcare expenditure and expanding access to advanced treatment modalities. With a favourable regulatory environment and growing awareness about cancer care, the Asia Pacific IGRT market is poised for continued growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to high prevalence of cancer and robust healthcare infrastructure. The United States dominates the market, driven by extensive research and development activities, along with significant investments in healthcare technology. Increasing adoption of advanced imaging technologies and software solutions, coupled with favourable reimbursement policies, propels market expansion. With a focus on precision medicine and patient-centric care, the North American IGRT market is poised for sustained growth and technological advancements.

Key players in the market

Some of the key players profiled in the Image Guided Radiotherapy Market include Siemens Healthineers, Elekta AB, Accuray Incorporated, ViewRay, Inc., Brainlab AG, RaySearch Laboratories, Mevion Medical Systems, C-RAD AB, IBA Dosimetry GmbH, Philips Healthcare, Hitachi Medical Systems, Theragenics Corporation, Nanobiotix and Xstrahl Limited.

Key Developments:

In March 2024, Siemens Healthineers and Varian Medical Systems announced the launch of their Image Guided Radiotherapy (IGR) product. The product helps practitioners provide digital image data for diagnosis, risk stratification, and treatment planning in the early stages of liver cancer detection. The data can also provide guidance and support during care.

In February 2024, Royal Philips, a health technology company, announced the launch of the Azurion neuro biplane system, a new version of its Image Guided Therapy (IGT) platform. The Azurion platform is powered by ConnectOS, a new operating system from Philips that optimizes system integration.

Products Covered:

  • Software
  • Hardware
  • Accessories
  • Service

Technologies Covered:

  • Cone Beam Computed Tomography (CBCT)
  • 3D Ultrasound
  • MRI-guided Radiation Therapy (MRI-RT)
  • Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
  • Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
  • Other Technologies

Applications Covered:

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Brain Tumours
  • Gynaecological Cancer
  • Other Applications

End Users Covered:

  • Hospitals
  • Radiation Therapy Centers
  • Cancer Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Image Guided Radiotherapy Market, By Product

  • 5.1 Introduction
  • 5.2 Software
    • 5.2.1 Treatment Planning Software
    • 5.2.2 Image Processing Software
    • 5.2.3 Image Registration Software
    • 5.2.4 Treatment Delivery Software
    • 5.2.5 Quality Assurance Software
  • 5.3 Hardware
    • 5.3.1 Linear Accelerators (LINAC)
    • 5.3.2 X-ray Systems
    • 5.3.3 Ultrasound Systems
  • 5.4 Accessories
    • 5.4.1 IGRT Tables
    • 5.4.2 IGRT Couches
    • 5.4.3 IGRT Markers
    • 5.4.4 IGRT Calibrators
    • 5.4.5 IGRT Immobilization Devices
  • 5.5 Service
    • 5.5.1 Installation Services
    • 5.5.2 Maintenance and Repair Services

6 Global Image Guided Radiotherapy Market, By Technology

  • 6.1 Introduction
  • 6.2 Cone Beam Computed Tomography (CBCT)
  • 6.3 3D Ultrasound
  • 6.4 MRI-guided Radiation Therapy (MRI-RT)
  • 6.5 Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
  • 6.6 Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
  • 6.7 Other Technologies

7 Global Image Guided Radiotherapy Market, By Application

  • 7.1 Introduction
  • 7.2 Prostate Cancer
  • 7.3 Breast Cancer
  • 7.4 Lung Cancer
  • 7.5 Head and Neck Cancer
  • 7.6 Brain Tumours
  • 7.7 Gynaecological Cancer
  • 7.8 Other Applications

8 Global Image Guided Radiotherapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Radiation Therapy Centers
  • 8.4 Cancer Research Institutes
  • 8.5 Other End Users

9 Global Image Guided Radiotherapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Siemens Healthineers
  • 11.2 Elekta AB
  • 11.3 Accuray Incorporated
  • 11.4 ViewRay, Inc.
  • 11.5 Brainlab AG
  • 11.6 RaySearch Laboratories
  • 11.7 Mevion Medical Systems
  • 11.8 C-RAD AB
  • 11.9 IBA Dosimetry GmbH
  • 11.10 Philips Healthcare
  • 11.11 Hitachi Medical Systems
  • 11.12 Theragenics Corporation
  • 11.13 Nanobiotix
  • 11.14 Xstrahl Limited

List of Tables

  • Table 1 Global Image Guided Radiotherapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Image Guided Radiotherapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Image Guided Radiotherapy Market Outlook, By Software (2021-2030) ($MN)
  • Table 4 Global Image Guided Radiotherapy Market Outlook, By Treatment Planning Software (2021-2030) ($MN)
  • Table 5 Global Image Guided Radiotherapy Market Outlook, By Image Processing Software (2021-2030) ($MN)
  • Table 6 Global Image Guided Radiotherapy Market Outlook, By Image Registration Software (2021-2030) ($MN)
  • Table 7 Global Image Guided Radiotherapy Market Outlook, By Treatment Delivery Software (2021-2030) ($MN)
  • Table 8 Global Image Guided Radiotherapy Market Outlook, By Quality Assurance Software (2021-2030) ($MN)
  • Table 9 Global Image Guided Radiotherapy Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 10 Global Image Guided Radiotherapy Market Outlook, By Linear Accelerators (LINAC) (2021-2030) ($MN)
  • Table 11 Global Image Guided Radiotherapy Market Outlook, By X-ray Systems (2021-2030) ($MN)
  • Table 12 Global Image Guided Radiotherapy Market Outlook, By Ultrasound Systems (2021-2030) ($MN)
  • Table 13 Global Image Guided Radiotherapy Market Outlook, By Accessories (2021-2030) ($MN)
  • Table 14 Global Image Guided Radiotherapy Market Outlook, By IGRT Tables (2021-2030) ($MN)
  • Table 15 Global Image Guided Radiotherapy Market Outlook, By IGRT Couches (2021-2030) ($MN)
  • Table 16 Global Image Guided Radiotherapy Market Outlook, By IGRT Markers (2021-2030) ($MN)
  • Table 17 Global Image Guided Radiotherapy Market Outlook, By IGRT Calibrators (2021-2030) ($MN)
  • Table 18 Global Image Guided Radiotherapy Market Outlook, By IGRT Immobilization Devices (2021-2030) ($MN)
  • Table 19 Global Image Guided Radiotherapy Market Outlook, By Service (2021-2030) ($MN)
  • Table 20 Global Image Guided Radiotherapy Market Outlook, By Installation Services (2021-2030) ($MN)
  • Table 21 Global Image Guided Radiotherapy Market Outlook, By Maintenance and Repair Services (2021-2030) ($MN)
  • Table 22 Global Image Guided Radiotherapy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 23 Global Image Guided Radiotherapy Market Outlook, By Cone Beam Computed Tomography (CBCT) (2021-2030) ($MN)
  • Table 24 Global Image Guided Radiotherapy Market Outlook, By 3D Ultrasound (2021-2030) ($MN)
  • Table 25 Global Image Guided Radiotherapy Market Outlook, By MRI-guided Radiation Therapy (MRI-RT) (2021-2030) ($MN)
  • Table 26 Global Image Guided Radiotherapy Market Outlook, By Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT) (2021-2030) ($MN)
  • Table 27 Global Image Guided Radiotherapy Market Outlook, By Computed Tomography (CT) -guided Radiation Therapy (CT-RT) (2021-2030) ($MN)
  • Table 28 Global Image Guided Radiotherapy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 29 Global Image Guided Radiotherapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Global Image Guided Radiotherapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 31 Global Image Guided Radiotherapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 32 Global Image Guided Radiotherapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 33 Global Image Guided Radiotherapy Market Outlook, By Head and Neck Cancer (2021-2030) ($MN)
  • Table 34 Global Image Guided Radiotherapy Market Outlook, By Brain Tumours (2021-2030) ($MN)
  • Table 35 Global Image Guided Radiotherapy Market Outlook, By Gynaecological Cancer (2021-2030) ($MN)
  • Table 36 Global Image Guided Radiotherapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 Global Image Guided Radiotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 Global Image Guided Radiotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 39 Global Image Guided Radiotherapy Market Outlook, By Radiation Therapy Centers (2021-2030) ($MN)
  • Table 40 Global Image Guided Radiotherapy Market Outlook, By Cancer Research Institutes (2021-2030) ($MN)
  • Table 41 Global Image Guided Radiotherapy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.